Isturisa
Chemical Name | osilodrostat |
Dosage Form | Tablets (oral; 1 mg, 5 mg, 10 mg) |
Drug Class | Inhibitors |
System | Endocrine |
Company | Recordati Rare Disease, Inc. |
Approval Year | 2020 |
Indication
- Indicated for the treatment of adult patients with Cushing’s disease for whom pituitary surgery is not an option or has not been curative.